112 related articles for article (PubMed ID: 15896841)
1. Establishment of a novel human B-CLL-like xenograft model in nude mouse.
Loisel S; Ster KL; Quintin-Roue I; Pers JO; Bordron A; Youinou P; Berthou C
Leuk Res; 2005 Nov; 29(11):1347-52. PubMed ID: 15896841
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
Mohammad RM; Mohamed AN; Hamdan MY; Vo T; Chen B; Katato K; Abubakr YA; Dugan MC; al-Katib A
Leukemia; 1996 Jan; 10(1):130-7. PubMed ID: 8558918
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
4. Establishment of ascitic tumor of human pre-B acute lymphoblastic leukemia in nonconditioned nude mice.
Luo Y; Hara H; Haruta Y; Seon BK
Cancer Res; 1989 Feb; 49(3):706-10. PubMed ID: 2783384
[TBL] [Abstract][Full Text] [Related]
5. [Establishment of a human esophageal carcinoma transplantation model with MUC1 high expression in nude mice].
Deng YJ; Rong TH; Zhou J; Song HF; Wang QJ; Huang LX; Chen SP; Li YQ; Xia JC
Ai Zheng; 2007 Jul; 26(7):693-7. PubMed ID: 17626742
[TBL] [Abstract][Full Text] [Related]
6. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
[TBL] [Abstract][Full Text] [Related]
7. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
[TBL] [Abstract][Full Text] [Related]
9. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
[TBL] [Abstract][Full Text] [Related]
11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
12. Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions.
Bertilaccio MT; Scielzo C; Simonetti G; Ten Hacken E; Apollonio B; Ghia P; Caligaris-Cappio F
Leukemia; 2013 Mar; 27(3):534-40. PubMed ID: 23041721
[TBL] [Abstract][Full Text] [Related]
13. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.
Yang BW; Liang Y; Xia JL; Sun HC; Wang L; Zhang JB; Tang ZY; Liu KD; Chen J; Xue Q; Chen J; Gao DM; Wu WZ
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1077-84. PubMed ID: 19047839
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
15. Engraftment of chronic prolymphocytic and T cell leukemia in SCID mice.
O'Brien S; Jeha S; Kantarjian H; Pisa P; Jin G; Keating M; Beran M
Leukemia; 1996 Feb; 10(2):338-44. PubMed ID: 8637244
[TBL] [Abstract][Full Text] [Related]
16. Animal models for chronic lymphocytic leukemia.
Pekarsky Y; Zanesi N; Aqeilan RI; Croce CM
J Cell Biochem; 2007 Apr; 100(5):1109-18. PubMed ID: 17131382
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
Ruan HY; Li DR; Li L; Guan X; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
[TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
19. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
20. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]